Caxton Associates LLP Grows Position in Cannae Holdings, Inc. $CNNE

Caxton Associates LLP grew its position in shares of Cannae Holdings, Inc. (NYSE:CNNE) by 33.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 177,299 shares of the company’s stock after purchasing an additional 44,756 shares during the quarter. Caxton Associates LLP owned approximately 0.40% of Cannae worth $2,016,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Quantbot Technologies LP acquired a new position in shares of Cannae during the 2nd quarter worth approximately $62,000. Kelleher Financial Advisors purchased a new stake in Cannae in the 3rd quarter worth $73,000. Parallel Advisors LLC purchased a new stake in Cannae in the 1st quarter worth $50,000. Eurizon Capital SGR S.p.A. acquired a new position in Cannae during the fourth quarter worth $85,000. Finally, CWM LLC raised its position in Cannae by 79.9% during the fourth quarter. CWM LLC now owns 7,313 shares of the company’s stock worth $115,000 after acquiring an additional 3,248 shares during the period. Institutional investors and hedge funds own 88.12% of the company’s stock.

Cannae Trading Up 2.4%

Shares of CNNE stock opened at $14.71 on Friday. The company’s 50-day moving average price is $14.34 and its 200-day moving average price is $13.65. Cannae Holdings, Inc. has a twelve month low of $10.46 and a twelve month high of $21.88. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.07. The stock has a market cap of $646.37 million, a price-to-earnings ratio of -1.88 and a beta of 1.20.

Cannae (NYSE:CNNE) last announced its quarterly earnings results on Monday, May 11th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.30). The firm had revenue of $96.20 million for the quarter, compared to analyst estimates of $99.77 million. Cannae had a negative return on equity of 36.53% and a negative net margin of 103.77%.The firm’s quarterly revenue was down 6.8% on a year-over-year basis. During the same quarter in the prior year, the business earned ($1.81) EPS. As a group, equities analysts predict that Cannae Holdings, Inc. will post -2.4 earnings per share for the current year.

Cannae Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date of this dividend was Tuesday, June 16th. Cannae’s dividend payout ratio (DPR) is presently -7.68%.

Wall Street Analyst Weigh In

CNNE has been the topic of several research analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cannae in a research report on Monday, July 6th. Stephens restated an “overweight” rating and set a $17.00 price target on shares of Cannae in a research report on Thursday, April 23rd. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Cannae in a research note on Tuesday, May 12th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $17.00.

Cannae Company Profile

Cannae Holdings, Inc (NYSE: CNNE) is a publicly traded diversified holding company that focuses on partnering with and investing in businesses across a range of industry sectors. The company seeks to identify attractive opportunities in both private and public markets, leveraging its capital resources and management expertise to support operational growth and value creation. Cannae’s investment strategy emphasizes companies in data and analytics, marketing services, healthcare technology, and payment processing.

Through its portfolio, Cannae holds controlling or significant minority stakes in companies that provide critical software, data and services to corporate clients.